| abstract |
A method to treat HIV and other retroviral infections by administering a novel conjugate or the precursors to the conjugate is described. In a preferred embodiment, the individual components, Lucifer Yellow and a derivative of Lucifer Yellow with aromatic compounds having carbonyl functional groups for reaction with the semicarbazide moiety of Lucifer Yellow are used as precursors in pharmaceutical compositions for HIV treatment. |